Evaluation of IAUGC indices and two DCE-MRI pharmacokinetic parameters assessed by two different theoretical algorithms in patients with brain tumors

Clinical Imaging

Volumn 38, Issue 6, 2014, Pages 808-814

  Bergamino, Maurizio ^a   Barletta, Laura ^b   Castellan, Lucio ^b   Saitta, Laura ^b   Mancardi, Giovanni Luigi ^a   Roccatagliata, Luca ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Brain tumors; Brain blood barrier permeability; DCE MRI; Extended tofts kety model; IAUGC

Indexed keywords

ALGORITHMS; BLOOD; BRAIN; CURVE FITTING; PARAMETER ESTIMATION; PHARMACOKINETICS; TUMORS;

ARTERIAL INPUT FUNCTION; BRAIN TUMORS; DCE-MRI; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; IAUGC; PHARMACOKINETIC MODEL; PHARMACOKINETIC PARAMETERS; THEORETICAL ALGORITHMS;

MAGNETIC RESONANCE IMAGING;

GADOBUTROL; CONTRAST MEDIUM; GADOLINIUM;

ADULT; AGED; ANALYTICAL PARAMETERS; AREA UNDER THE CURVE; ARTERIAL INPUT FUNCTION; ARTICLE; BLOOD BRAIN BARRIER; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXTENDED TOFTS KETY MODEL; FEMALE; GLIOBLASTOMA; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGING AND DISPLAY; MALE; MIDDLE AGED; MODEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TOFTS KETY MODEL; ALGORITHM; BRAIN; BRAIN NEOPLASMS; DIAGNOSTIC USE; IMAGE ENHANCEMENT; PATHOLOGY; PROCEDURES;

AGED; ALGORITHMS; AREA UNDER CURVE; BRAIN; BRAIN NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84927690670     PISSN: 08997071     EISSN: 18734499     Source Type: Journal    
DOI: 10.1016/j.clinimag.2014.07.008     Document Type: Article

References (54)

1. Rowland LP, Fink ME, Rubin L Cerebrospinal fluid: blood-brain barrier, brain edema, and hydrocephalus. Principles of neural science 2001, 1050-1060. Elsevier, New York. 3rd ed.
2. Fukumura D, Xu L, Chen Y, Gohongi T, Seed B, Jain RK Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 2001, 61:6020-6024.
3. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 1994, 54:4564-4568.
4. Bullitt E, Zeng D, Gerig G, Aylward S, Joshi S, Smith JK, Lin W, Ewend MG Vessel tortuosity and brain tumor malignancy: a blinded study. Acad Radiol 2005, 12:1232-1240.
5. Zagzag D, Hooper A, Friedlander DR, Chan W, Holash J, Wiegand SJ, Yancopoulos GD, Grumet M In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp Neurol 1999, 159:391-400.
6. Vick NA, Bigner DD Microvascular abnormalities in virally-induced canine brain tumors. Structural bases for altered blood-brain barrier function. J Neurol Sci 1972, 17:29-39.
7. Waggener JD, Beggs JL Vasculature of neural neoplasms. Adv Neurol 1976, 15:27-49.
8. Yau T, Chen PJ, Chan P, Curtis CM, Murphy PS, Suttle AB, Gauvin J, Hodge JP, Dar MM, Poon RT Phase I dose-finding study of pazopanib in hepatocellular carcinoma: evaluation of early efficacy, pharmacokinetics, and pharmacodynamics. Clin Cancer Res 2011, 17:6914-6923.
9. Awasthi R, Pandey CM, Sahoo P, Behari S, Kumar V, Kumar S, Misra S, Husain N, Soni P, Rathore RK, Gupta RK Dynamic contrast-enhanced magnetic resonance imaging-derived kep as a potential biomarker of matrix metalloproteinase 9 expression in patients with glioblastoma multiforme: a pilot study. J Comput Assist Tomogr 2012, 36:125-130.
10. Haris M, Husain N, Singh A, Awasthi R, Singh Rathore RK, Husain M, Gupta RK Dynamic contrast-enhanced (DCE) derived transfer coefficient (ktrans) is a surrogate marker of matrix metalloproteinase 9 (MMP-9) expression in brain tuberculomas. J Magn Reson Imaging 2008, 28:588-597.
11. Gossmann A, Helbich TH, Kuriyama N, Ostrowitzki S, Roberts TP, Shames DM, van Bruggen N, Wendland MF, Israel MA, Brasch RC Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. J Magn Reson Imaging 2002, 15:233-240.
12. Yankeelov TE, Lepage M, Chakravarthy A, Broome EE, Niermann KJ, Kelley MC, Meszoely I, Mayer IA, Herman CR, McManus K, Price RR, Gore JC Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 2007, 25:1-13.
13. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999, 10:223-232.
14. Tofts PS Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997, 7:91-101.
15. Buckley DL Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 2002, 47:601-606.
16. Bergamino M, Saitta L, Barletta L, Bonzano L, Mancardi GL, Castellan L, Ravetti JL, Roccatagliata L Measurement of blood-brain barrier permeability with T1-weighted dynamic contrast-enhanced MRI in brain tumors: a comparative study with two different algorithms. ISRN Neurosci 2013, 2013. [6 pages].
17. Kershaw LE, Cheng HL Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model. Magn Reson Med 2010, 64:1772-1780.
18. Larsson HB, Courivaud F, Rostrup E, Hansen AE Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T(1)-weighted MRI at 3 tesla. Magn Reson Med 2009, 62:1270-1281.
19. Koh TS, Zeman V, Darko J, Lee TY, Milosevic MF, Haider M, Warde P, Yeung IW The inclusion of capillary distribution in the adiabatic tissue homogeneity model of blood flow. Phys Med Biol 2001, 46:1519-1538.
20. Donaldson SB, West CM, Davidson SE, Carrington BM, Hutchison G, Jones AP, Sourbron SP, Buckley DL A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix. Magn Reson Med 2010, 63:691-700.
21. Luypaert R, Sourbron S, de Mey J Validity of perfusion parameters obtained using the modified Tofts model: a simulation study. Magn Reson Med 2011, 65:1491-1497.
22. Harrer JU, Parker GJ, Haroon HA, Buckley DL, Embelton K, Roberts C, Baleriaux D, Jackson A Comparative study of methods for determining vascular permeability and blood volume in human gliomas. J Magn Reson Imaging 2004, 20:748-757.
23. Tofts PS, Kermode AG Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991, 17:357-367.
24. Walker S, Dzik-Jurasz A, d'Arcy JA, Leach M, Collins DJ Evaluation of area under curve [Gd] data derived from DCE-MRI time series in brain tumours. Proc Int Soc Magn Reson Med 2003, 11:1267.
25. Parker GJ, Buckley DL Dynamic contrast-enhanced magnetic resonance imaging in oncology 2005.
26. Walker-Samuel S, Leach MO, Collins DJ Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis. Phys Med Biol 2006, 51:3593-3602.
27. Breault SR, Heye T, Bashir MR, Dale BM, Merkle EM, Reiner CS, Faridi KF, Gupta RT Quantitative dynamic contrast-enhanced MRI of pelvic and lumbar bone marrow: effect of age and marrow fat content on pharmacokinetic parameter values. AJR Am J Roentgenol 2013, 200:W297-W303.
28. Zhao Q, Lee S, Kent M, Schatzberg S, Platt S Dynamic contrast-enhanced magnetic resonance imaging of canine brain tumors. Vet Radiol Ultrasound 2010, 51:122-129.
29. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994, 191:41-51.
30. Ludemann L, Grieger W, Wurm R, Wust P, Zimmer C Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI. Magn Reson Imaging 2005, 23:833-841.
31. Cha S, Tihan T, Crawford F, Fischbein NJ, Chang S, Bollen A, Nelson SJ, Prados M, Berger MS, Dillon WP Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2005, 26:266-273.
32. Law M, Brodsky JE, Babb J, Rosenblum M, Miller DC, Zagzag D, Gruber ML, Johnson G High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: preliminary results of molecular studies in gliomas with elevated perfusion. J Magn Reson Imaging 2007, 25:1113-1119.
33. Roberts C, Issa B, Stone A, Jackson A, Waterton JC, Parker GJ Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies. J Magn Reson Imaging 2006, 23:554-563.
34. Deoni SC, Rutt BK, Peters TM Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med 2003, 49:515-526.
35. Stanisz GJ, Henkelman RM Gd-DTPA relaxivity depends on macromolecular content. Magn Reson Med 2000, 44:665-667.
36. Weinmann HJ, Laniado M, Mutzel W Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984, 16:167-172.
37. Kassner A, Mandell DM, Mikulis DJ Measuring permeability in acute ischemic stroke. Neuroimaging Clin N Am 2011, 21:315-325. [x-xi].
38. Gaitan MI, Shea CD, Evangelou IE, Stone RD, Fenton KM, Bielekova B, Massacesi L, Reich DS Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol 2011, 70:22-29.
39. Taheri S, Gasparovic C, Huisa BN, Adair JC, Edmonds E, Prestopnik J, Grossetete M, Shah NJ, Wills J, Qualls C, Rosenberg GA Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke 2011, 42:2158-2163.
40. Viggars AP, Wharton SB, Simpson JE, Matthews FE, Brayne C, Savva GM, Garwood C, Drew D, Shaw PJ, Ince PG Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: a study in the MRC-CFAS population neuropathology cohort. Neurosci Lett 2011, 505:25-30.
41. Padhani AR, Hayes C, Landau S, Leach MO Reproducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed 2002, 15:143-153.
42. O'Connor JP, Jackson A, Asselin MC, Buckley DL, Parker GJ, Jayson GC Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives. Lancet Oncol 2008, 9:766-776.
43. Parker GJ, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, Buckley DL, Jackson A, Watson Y, Davies K, Jayson GC Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006, 56:993-1000.
44. Evelhoch JL Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999, 10:254-259.
45. Gaya A, Daley F, Taylor NJ, Tozer G, Qureshi U, Padhani A, Pedley RB, Begent R, Wellsted D, Stirling JJ, Rustin G Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study. Br J Cancer 2008, 99:321-326.
46. Barrett T, Gill AB, Kataoka MY, Priest AN, Joubert I, McLean MA, Graves MJ, Stearn S, Lomas DJ, Griffiths JR, Neal D, Gnanapragasam VJ, Sala E DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study. Magn Reson Med 2011, 67:778-785.
47. Lankester KJ, Taylor JN, Stirling JJ, Boxall J, d'Arcy JA, Collins DJ, Walker-Samuel S, Leach MO, Rustin GJ, Padhani AR Dynamic MRI for imaging tumor microvasculature: comparison of susceptibility and relaxivity techniques in pelvic tumors. J Magn Reson Imaging 2007, 25:796-805.
48. Barrett T, Gill A, Kataoka M, Gnanapragasam VJ, Priest A, Joubert I, McLean M, Graves MJ, Lomas DJ, Griffiths JR, Neal D, Sala E DCE-MRI at 3T in patients with advanced prostate cancer undergoing androgen deprivation therapy. Proc Int Soc Magn Reson Med 2010, 18:2801.
49. Kim KW, Lee JM, Jeon YS, Lee IJ, Choi Y, Park J, Kiefer B, Kim C, Han JK, Choi BI Vascular disrupting effect of CKD-516: preclinical study using DCE-MRI. Invest New Drugs 2013, 31:1097-1106.
50. Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL Dynamic contrast-enhanced MRI of prostate cancer at 3T: a study of pharmacokinetic parameters. AJR Am J Roentgenol 2007, 189:849-858.
51. Lankester KJ, Taylor NJ, Stirling JJ, Boxall J, D'Arcy JA, Leach MO, Rustin GJ, Padhani AR Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRI. Br J Cancer 2005, 93:979-985.
52. Buckley DL, Roberts C, Parker GJ, Logue JP, Hutchinson CE Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging-initial experience. Radiology 2004, 233:709-715.
53. Rijpkema M, Kaanders JH, Joosten FB, van der Kogel AJ, Heerschap A Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging 2001, 14:457-463.
54. Li KL, Zhu XP, Waterton J, Jackson A Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 2000, 12:347-357.